positions available now

Tag Archives: Market Access

Commercial Eyes Recruiting: Associate Director, Market Access and Pricing

  The Company Commercial Eyes is Australia’s leading Pharmaceutical and Medical Device commercialisation consultancy offering pre and post market advice and support to local and international companies operating in Australia & New Zealand.  We provide a full suite of services … Continue reading

Posted in Commercial Eyes, Market Access, Recruiting | Tagged , , , , | Comments Off on Commercial Eyes Recruiting: Associate Director, Market Access and Pricing

PBAC Outcomes – November 2019

The November 2019 PBAC Meeting Outcomes were published recently With 61 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making for this meeting, compared to the past 5 years of outcomes. Of note, … Continue reading

Posted in Market Access, PBAC | Tagged , , , | Comments Off on PBAC Outcomes – November 2019

Pharmac reverses controversial brand switch decision

Pharmac has been placed in the spotlight over their decision earlier in the year to fund only one brand of anti-epileptic medication, lamotrigine, instead of the previously funded three lamotrigine brands. Prior to the switch, Medsafe warned Pharmac that the … Continue reading

Posted in Market Access | Tagged , , , , | Comments Off on Pharmac reverses controversial brand switch decision

Commercial Eyes appoints Simon Higgins to head up new Commercialisation Services division

Commercial Eyes Pty. Ltd., one of Australia’s most successful health technology commercialisation companies, is pleased to announce the appointment of Simon Higgins to head up it’s new Commercialisation Services division. Simon joins Commercial Eyes with over 20 years’ experience in … Continue reading

Posted in Commercial Eyes, Commercialisation Services, Market Access, Market Insight, Medical Communications, Medical Services, Regulatory Services | Tagged , , , , | Comments Off on Commercial Eyes appoints Simon Higgins to head up new Commercialisation Services division

PHARMAC issues a call for funding applications for medicines for rare disorders

Applications will be accepted until 5pm on the 5th of August 2019 and will be considered by the Rare Disorders Subcommittee at their meeting scheduled for the 24th of September 2019.   Eligibility criteria: The medicine must have been approved … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on PHARMAC issues a call for funding applications for medicines for rare disorders

PBAC Meeting Outcomes – July 2018

The July 2018 PBAC Meeting Outcomes were published on 17th August 2018. With 64 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including additional analysis conducted on biosimilar and oncology submissions.   … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , | Comments Off on PBAC Meeting Outcomes – July 2018

PBAC Special Meeting – August 2018

The August 2018 PBAC special meeting is scheduled for 17 August 2018 to consider options for listing PD-1 and PD-L1 checkpoint inhibitors for the treatment of multiple tumours (pan-tumour indications) on the PBS. Here, the Commercial Eyes Market Access team … Continue reading

Posted in Market Access, PBAC | Tagged , , , , , | Comments Off on PBAC Special Meeting – August 2018

The long road to PBS listing for Orkambi

Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , | Comments Off on The long road to PBS listing for Orkambi

PBAC Meeting Agenda – July 2018

The July 2018 PBAC Meeting is scheduled from 4 to 6 Jul 2018. Here, the Commercial Eyes Market Access team provides an overview of the meeting agenda, including submissions relating to biosimilars lodged for this meeting.     The Commercial … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , , , | Comments Off on PBAC Meeting Agenda – July 2018

PBAC Meeting Outcomes – March 2018

The March 2018 PBAC Meeting Outcomes were published on 20th April 2018. With 71 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including an additional analysis conducted on oncology submissions which have … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , , | Comments Off on PBAC Meeting Outcomes – March 2018
Copyright © 2014 Commercial Eyes